Effect of Recombinant Human Thrombopoietin (rhTPO) on Long-term Hematopoietic Recovery in Mice with Acute Radiation Sickness and Relative Mechanism.
10.19746/j.cnki.issn.1009-2137.2023.02.034
- Author:
Hao LUAN
1
;
Shuang XING
2
;
Jing-Kun YANG
3
;
Ye-Mei WANG
4
;
Xue-Wen ZHANG
3
;
Zi-Zhi QIAO
3
;
Xing SHEN
3
;
Zu-Yin YU
5
Author Information
1. School of Life Science, Anhui Medical University, Hefei 230032, Anhui Province, China,Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing 100850, China.
2. Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing 100850, China,xshuang6564@163.com.
3. Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing 100850, China.
4. Graduate School of Jinzhou Medical University, Jinzhou 121001, Liaoning Province, China.
5. School of Life Science, Anhui Medical University, Hefei 230032, Anhui Province, China,Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing 100850, China,E-mail: yuzy79@163.com.
- Publication Type:Journal Article
- Keywords:
acute radiation sickness;
long term myelosuppression;
recombinant human thrombopoietin
- MeSH:
Humans;
Mice;
Animals;
Thrombopoietin/metabolism*;
Hematopoietic Stem Cells;
Blood Platelets;
Recombinant Proteins/therapeutic use*;
Radiation Injuries;
RNA, Messenger/metabolism*
- From:
Journal of Experimental Hematology
2023;31(2):546-552
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the effect and relative mechanism of Recombinant Human Thrombopoietin (rhTPO) on long-term hematopoietic recovery in mice with acute radiation sickness.
METHODS:Mice were intramuscularly injected with rhTPO (100 μg/kg) 2 hours after total body irradiation with 60Co γ-rays (6.5 Gy). Moreover, six months after irradiation, peripheral blood, hematopoietic stem cells (HSC) ratio, competitive transplantation survival rate and chimerization rate, senescence rate of c-kit+ HSC, and p16 and p38 mRNA expression of c-kit+ HSC were detected.
RESULTS:Six months after 6.5 Gy γ-ray irradiation, there were no differences in peripheral blood white blood cells, red blood cells, platelets, neutrophils and bone marrow nucleated cells in normal group, irradiated group and rhTPO group (P>0.05). The proportion of hematopoietic stem cells and multipotent progenitor cells in mice of irradiated group was significantly decreased after irradiation (P<0.05), but there was no significant changes in rhTPO group (P>0.05). The counts of CFU-MK and BFU-E in irradiated group were significantly lower than that in normal group, and rhTPO group was higher than that of the irradiated group(P<0.05). The 70 day survival rate of recipient mice in normal group and rhTPO group was 100%, and all mice died in irradiation group. The senescence positive rates of c-kit+ HSC in normal group, irradiation group and rhTPO group were 6.11%, 9.54% and 6.01%, respectively (P<0.01). Compared with the normal group, the p16 and p38 mRNA expression of c-kit+ HSC in the irradiated mice were significantly increased (P<0.01), and it was markedly decreased after rhTPO administration (P<0.01).
CONCLUSION:The hematopoietic function of mice is still decreased 6 months after 6.5 Gy γ-ray irradiation, suggesting that there may be long-term damage. High-dose administration of rhTPO in the treatment of acute radiation sickness can reduce the senescence of HSC through p38-p16 pathway and improve the long-term damage of hematopoietic function in mice with acute radiation sickness.
